Overview: RSV IgM TestIntroduction: The RSV IgM Test tests for RSV IgM antibodies to diagnose recent RSV infection, helping manage respiratory symptoms like cough or wheezing. Affecting 1 in 50 infants annually, recent RSV infection poses diagnostic challenges due to short antibody window. Following 2023 Centers for Disease Control and Prevention (CDC) guidelines, it uses ELISA for high accuracy, supporting virology screening. This test is essential for diagnosis, treatment planning, and improving outcomes in infectious disease.
Other Names: RSV IgM Antibody Test, Recent RSV Assay.
FDA Status: Laboratory-developed test (LDT), meeting virology standards for diagnostic reliability.
Historical Milestone: RSV IgM testing began in the 1980s with research by Welliver, who identified early antibodies. ELISA advancements in the 1990s by Thermo Fisher improved detection, surpassing earlier immunofluorescence methods.
Purpose: Detects RSV IgM levels to diagnose recent infection, guides supportive care, and evaluates patients with respiratory symptoms, aiming to manage disease.
Test Parameters: RSV IgM levels
Pretest Condition: No special preparation required. Collect serum. Report history of respiratory issues.
Specimen: Serum (SST, 2-5 mL); 2 mL serum in SST. Transport in a biohazard container.
Sample Stability at Room Temperature: 6 hours
Sample Stability at Refrigeration: 1 week
Sample Stability at Frozen: 1 month
Medical History: Document recent respiratory symptoms. Include current medications or exposure history.
Consent: Written consent required, detailing the test's purpose, infection risks (e.g., bronchiolitis), and sample collection risks.
Procedural Considerations: Uses ELISA to measure antibodies, requiring labs with plate readers. Results available in 3-5 days. Performed in labs with strict handling.
Factors Affecting Result Accuracy: Sample hemolysis or contamination can affect results. Medications may not affect results but require correlation.
Clinical Significance: Positive IgM suggests recent infection, guiding care. Early management might prevent complications, while untreated cases lead to worsening. Negative results may require other tests.
Specialist Consultation: Consult a pediatrician or infectious disease specialist for interpretation.
Additional Supporting Tests: RSV PCR, chest X-ray, or IgG levels to confirm diagnosis.
Test Limitations: Specific to recent infection; correlation with symptoms needed. False negatives possible outside IgM window.
References: CDC Guidelines, 2023; Pediatric Infectious Disease Journal, Welliver RC, 2022.
